Form D · Hedge Fund

Pearl Biotech & Life Sciences Fund, L.P.

Mclean, VA · CIK 0001635568

Offering snapshot reported Dec 30, 2025 · SEC filing

Reported sold
$4.61M
Indefinite offering
Investors reported
20
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 12, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.31M$4.61MOct 26, 2015Nov 27, 2018: $2,550,000.00Dec 5, 2019: $2,900,000.00Dec 21, 2020: $3,925,000.00Dec 20, 2021: $4,275,000.00Dec 21, 2022: $4,275,000.00Dec 20, 2023: $4,475,000.00Dec 30, 2024: $4,561,000.00Dec 30, 2025: $4,611,000.00Dec 30, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,561,000 → $4,611,000
  • Reported investors19 → 20

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 30, 2025Amendment$4,611,000$50,000vs Dec 30, 202420SEC filing
Dec 30, 2024Amendment$4,561,000$86,000vs Dec 20, 202319SEC filing
Dec 20, 2023Amendment$4,475,000$200,000vs Dec 21, 202218SEC filing
Dec 21, 2022Amendment$4,275,000$0vs Dec 20, 202118SEC filing
Dec 20, 2021Amendment$4,275,000$350,000vs Dec 21, 202018SEC filing
Dec 21, 2020Amendment$3,925,000$1,025,000vs Dec 5, 201916SEC filing
Dec 5, 2019Amendment$2,900,000$350,000vs Nov 27, 201812SEC filing
Nov 27, 2018Amendment$2,550,000No comparison12SEC filing
Oct 26, 2017AmendmentYet to sellNo comparison0SEC filing
Oct 31, 2016AmendmentYet to sellNo comparison0SEC filing
Oct 26, 2015InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-250050

Source: Form D, filed Dec 30, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Bravance Healthcare Investors, Llc Executive
Lynt Johnson Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
887 Centrillion Dr.
Mclean, VA, 22102